206 related articles for article (PubMed ID: 19515385)
1. Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer.
Shuno Y; Tsuno NH; Okaji Y; Tsuchiya T; Sakurai D; Nishikawa T; Yoshikawa N; Sasaki K; Hongo K; Tsurita G; Sunami E; Kitayama J; Tokunaga K; Takahashi K; Nagawa H
J Surg Res; 2010 Jun; 161(1):76-82. PubMed ID: 19515385
[TBL] [Abstract][Full Text] [Related]
2. Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer.
Tsuchiya T; Okaji Y; Tsuno NH; Sakurai D; Tsuchiya N; Kawai K; Yazawa K; Asakage M; Yamada J; Yoneyama S; Kitayama J; Osada T; Watanabe T; Tokunaga K; Takahashi K; Nagawa H
Cancer Sci; 2005 Nov; 96(11):784-90. PubMed ID: 16271072
[TBL] [Abstract][Full Text] [Related]
3. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Id1 and Id3 in endometrial carcinoma and their roles in regulating biological behaviors of endometrial carcinoma cells in vitro].
Sun L; Li X; Liu G
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):812-8. PubMed ID: 23803189
[TBL] [Abstract][Full Text] [Related]
5. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
Asirvatham AJ; Schmidt MA; Chaudhary J
Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.
Strong N; Millena AC; Walker L; Chaudhary J; Khan SA
Prostate; 2013 May; 73(6):624-33. PubMed ID: 23060149
[TBL] [Abstract][Full Text] [Related]
7. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
[TBL] [Abstract][Full Text] [Related]
8. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis.
Hong SH; Lee JH; Lee JB; Ji J; Bhatia M
J Cell Sci; 2011 May; 124(Pt 9):1445-52. PubMed ID: 21486943
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
Ling YX; Tao J; Fang SF; Hui Z; Fang QR
Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
[TBL] [Abstract][Full Text] [Related]
11. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
Damdinsuren B; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Yamamoto T; Marubashi S; Miyamoto A; Umeshita K; Dono K; Nakamori S; Wakasa K; Sakon M; Monden M
Int J Oncol; 2005 Feb; 26(2):319-27. PubMed ID: 15645115
[TBL] [Abstract][Full Text] [Related]
12. Effects of down-regulating the Id genes in human colorectal cancer cells on early steps of haematogenous metastasis.
Okaji Y; Tsuno NH; Kitayama J; Sakurai D; Tsuchiya N; Saito S; Takegami K; Tsuchiya T; Kawai K; Yazawa K; Asakage M; Yoneyama S; Yamada J; Tokunaga K; Takahashi K; Nagawa H
Eur J Cancer; 2006 Mar; 42(5):668-73. PubMed ID: 16427272
[TBL] [Abstract][Full Text] [Related]
13. The expression and roles of inhibitor of DNA binding helix-loop-helix proteins in the developing and adult mouse retina.
Du Y; Yip HK
Neuroscience; 2011 Feb; 175():367-79. PubMed ID: 21145943
[TBL] [Abstract][Full Text] [Related]
14. ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21.
O'Brien CA; Kreso A; Ryan P; Hermans KG; Gibson L; Wang Y; Tsatsanis A; Gallinger S; Dick JE
Cancer Cell; 2012 Jun; 21(6):777-92. PubMed ID: 22698403
[TBL] [Abstract][Full Text] [Related]
15. Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation.
Ciarapica R; Annibali D; Raimondi L; Savino M; Nasi S; Rota R
Oncogene; 2009 Apr; 28(17):1881-91. PubMed ID: 19330020
[TBL] [Abstract][Full Text] [Related]
16. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
17. Silencing Id-1 with RNA interference inhibits adenoid cystic carcinoma in mice.
Chen Z; Liu S; Sumida T; Sun S; Wei Y; Liu M; Dong Z; Zhang F; Hamakawa H; Wei F
J Surg Res; 2011 Jul; 169(1):57-66. PubMed ID: 20189601
[TBL] [Abstract][Full Text] [Related]
18. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor of DNA binding 1 (Id1) induces differentiation and proliferation of mouse embryonic carcinoma P19CL6 cells.
Meng Q; Jia Z; Wang W; Li B; Ma K; Zhou C
Biochem Biophys Res Commun; 2011 Aug; 412(2):253-9. PubMed ID: 21820417
[TBL] [Abstract][Full Text] [Related]
20. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.
Chen YH; Wu ZQ; Zhao YL; Si YL; Guo MZ; Han WD
Chin Med J (Engl); 2012 Jul; 125(13):2329-33. PubMed ID: 22882857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
